Gestational trophoblastic neoplasia--pathogenesis and potential therapeutic targets (Q36871512)

16 August 2017

1 reference

title

Gestational trophoblastic neoplasia--pathogenesis and potential therapeutic targets (English)

1 reference

16 August 2017

Ie-Ming Shih

1 reference

16 August 2017

language of work or name

1 reference

1 July 2007

1 reference

Lancet Oncology Commission

16 August 2017

published in

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

page(s)

642-650

1 reference

Molecular basis of gestational trophoblastic diseases

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

The pathology of intermediate trophoblastic tumors and tumor-like lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Gestational trophoblastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Placental site nodule and characterization of distinctive types of intermediate trophoblast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Metastatic gestational choriocarcinoma. Unusual pathologic variant following therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Infrequent mutation in tumor suppressor gene p53 in gestational trophoblastic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif☆☆Sequence data from this article have been deposited with the DDBJ/EMBL/GenBank Data Libraries under Accession No. AB059410

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Human chromosome 7 carries a putative tumor suppressor gene(s) involved in choriocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Evaluation of deletions in 7q11.2 and 8p12–p21 as prognostic indicators of tumour development following molar pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Application of human leukocyte antigen-G expression in the diagnosis of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Placental site trophoblastic tumour arising from a partial hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Placental site trophoblastic tumor arising from antecedent molar pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Malignant trophoblastic neoplasms with different modes of origin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Placental site trophoblastic tumor--past as prologue

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Immunohistochemical analysis of cell cycle regulatory gene products in normal trophoblast and placental site trophoblastic tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor--an aid in differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

PTEN promoter methylation and protein expression in normal early placentas and hydatidiform moles.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

The c-Myc target gene network

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

The Myc oncoprotein as a therapeutic target for human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Cancer therapeutics: targeting the dark side of Myc.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Epidermal growth factor receptor targeting in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

P53 gene product and egf-receptor are highly expressed in placental site trophoblastic tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Activation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Exogenous amino acids regulate trophectoderm differentiation in the mouse blastocyst through an mTOR-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Osteopontin expression in gestational trophoblastic diseases: correlation with expression of the adhesion molecule, CEACAM1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Future directions in the treatment of hormone-sensitive advanced breast cancer: the RAD001 (Everolimus)-letrozole clinical program

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Mammalian target of rapamycin inhibitors in sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

Marimastat in the treatment of patients with biochemically relapsed prostate cancer: a prospective randomized, double-blind, phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970204-8

7 January 2021

10.1016/S1470-2045(07)70204-8

Identifiers

DOI

1 reference

16 August 2017

1 reference